BARETab SF 50 M

Description

BARETab® SF Composition: Microcrystalline Cellulose, Colloidal silicon dioxide, Croscarmellose sodium, Sodium Stearyl Fumarate.
BARETab® SF is ready to use excipient premix for directly compressible tablet formulation, it is composed of binder-filler, glidant, disintegrant, and lubricant. It can solve major formulation issues like less tablet hardness, poor disintegration time, and dissolution. It helps to improve the tablet’s appearance also. With BARETab SF can be manufactured in high and low-dose tablets.

 

Benefits of using BARETab SF

• Dust-free handling during production
• Enhanced lubrication efficiency
• Superior binding properties
• Higher surface area, helps to provide desired tablet hardness and Disintegration time
• High intrinsic flowability, which is help to increases API flowability
• Increases tablet compressibility
• Increased production capacity with Homogeneous product